Goran R.
- Country
- Croatia
- Department
- #8703;Dermatologija
Research Overview
Data & Insights
Has run more than one trial at 24 of 145 partner sites.
Specializations
Hematologic Disorders
The investigator specializes in treating various forms of myelofibrosis, including both primary myelofibrosis and secondary myelofibrosis conditions that develop following other blood disorders.
- Post-polycythemia vera myelofibrosis
- Post-essential thrombocythemia myelofibrosis
Particular focus is placed on managing cases with specific genetic characteristics, notably those with TP53 wild-type presentations.
Treatment Approaches
The investigator focuses on innovative therapeutic strategies for JAK inhibitor-resistant myelofibrosis, exploring combination therapies and alternative treatment pathways.
- Novel therapeutic combinations
- Treatment-resistant disease management
- Advanced-stage interventions
Special attention is given to patients with intermediate and high-risk disease profiles requiring specialized therapeutic approaches.
Clinical Outcomes
The investigator's therapeutic focus includes monitoring key clinical responses in myelofibrosis treatment, particularly spleen volume reduction and symptom score improvement.
- Spleen response assessment
- Symptom burden evaluation
- Treatment efficacy monitoring
Emphasis is placed on measuring therapeutic outcomes in patients with advanced myeloproliferative disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.